(S)-2-((tert-Butoxycarbonyl)amino)-2-(4-(trifluoromethoxy)phenyl)acetic acid, 95%, 1g

2,6-Dibromo-3-hydroxypyridine>97.0%(T)1g

(S)-1-(1-Phenylethyl)-1H-pyrrole-2,5-dione, 1g

3-(tert-Butoxycarbonylamino)-1-propanol>96.0%(GC)5mL

5-Bromo-2,3-difluorobenzoic acid, 95.0%, 1g

Potassium di-tert-butyl phosphate, 95.0%, 10g

2-(3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-oxopiperidin-1-yl)acetic acid, 95.0%, 100mg

2-(Pyridin-4-ylmethyl)-2,3-dihydro-1H-isoindole-1,3-dione dihydrate, 98.0%, 250mg

[1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]methanol, 250mg

fmoc-b-homo-d-tyr(tbu)-oh, 98.0%, 250mg

Methyl 4-fluoro-2-hydroxy-3-nitrobenzoate, 97%, 5g

2-(3,4-Difluorophenyl)morpholine hydrochloride, 95.0%, 1g

(E)-Methyl 3-(3-bromophenyl)acrylate, 95.0%, 10g